...
首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Harmonization in hemolysis detection and prevention. A working group of the Catalonian Health Institute (ICS) experience
【24h】

Harmonization in hemolysis detection and prevention. A working group of the Catalonian Health Institute (ICS) experience

机译:溶血检测和预防的协调。加泰罗尼亚卫生研究所(ICS)工作经验小组

获取原文
获取原文并翻译 | 示例

摘要

Background: Hemolysis is the main cause of non-quality samples in clinical laboratories, producing the highest percentage of rejections in the external assurance programs of preanalytical quality. The objective was to: 1) study the agreement between the detection methods and quantification of hemolysis; 2) establish comparable hemolysis interference limits for a series of tests and analytical methods; and 3) study the preanalytical variables which most influence hemolysis production.Methods: Different hemoglobin concentration standards were prepared using the reference method. Agreement was studied between automated methods [hemolytic indexes (HI)] and reference method, as well as the interference according to hemolysis degree in various biochemical tests was measured. Preanalytical variables which could influence hemolysis production were studied: type of extraction, type of tubes, transport time, temperature and centrifugation conditions.Results: Good agreement was obtained between hemoglobin concentrations measured using the reference method and HI, for the most of studied analyzers, particularly those giving quantitative HI. The hemolysis interference cut-off points obtained for the majority of tests studied (except LDH, K) are dependent on the method/analyzer utilized. Furthermore, discrepancies have been observed between interference limits recommended by the manufacturer. The preanalytical variables which produce a lower percentage of hemolysis rejections were: centrifugation at the extraction site, the use of lower volume tubes and a transport time under 15 min at room temperature.Conclusions: The setting of interference limits (cut-off) for each used test/method, and the study of preanalytical variability will assist to the results harmonization for this quality indicator.
机译:背景:溶血是临床实验室中不合格样品的主要原因,在分析前质量的外部保证程序中产生最高拒绝率。目的是:1)研究检测方法与溶血定量之间的一致性; 2)为一系列测试和分析方法建立可比较的溶血干扰限值;方法3:采用参考方法制备不同的血红蛋白浓度标准品。研究了自动方法[溶血指数(HI)]和参考方法之间的一致性,并测量了各种生化测试中溶血度对干扰的影响。研究了可能影响溶血产生的分析前变量:提取类型,试管类型,运输时间,温度和离心条件。结果:对于大多数研究的分析仪,使用参考方法测得的血红蛋白浓度与HI取得了很好的一致性,特别是那些给出定量HI的人。在大多数研究中(LDH,K除外)获得的溶血干扰截止点取决于所使用的方法/分析仪。此外,已经观察到制造商建议的干扰极限之间存在差异。产生较低溶血排斥率的分析前变量是:提取部位的离心作用,使用较小容量的试管和室温下15分钟内的运输时间。使用的测试/方法,以及分析前变异性的研究将有助于该质量指标的结果统一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号